The report provides a detailed analysis essential for establishing a Stanozolol production plant. It encompasses all critical aspects necessary for Stanozolol production, including the cost of Stanozolol production, Stanozolol plant cost, Stanozolol production costs, and the overall Stanozolol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Stanozolol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Stanozolol is a synthetic steroid that is widely used in both animal and human patients. It is a synthetic anabolic androgenic steroid (AAS) that is mainly used for the treatment of hereditary angioedema and various vascular disorders. Moreover, it also finds its application as a medication in the treatment of osteoporosis, bone fractures, and other conditions that cause muscle wasting. Additionally, the compound is often employed as a veterinary medicine to enhance muscle growth and treat poor appetite debilitated or weakened animals.
The demand for Stanozolol is primarily driven by its utilization as an orally active synthetic anabolic steroid used to reduce the frequency and severity of attacks of hereditary angioedema, which significantly fuels its market growth. Its utilization as an oral medication for the treatment of vascular disorders further enhances its demand in the healthcare and pharmaceutical industries. Moreover, its application in the veterinary industry to improve muscle growth in animals effectively promotes its market expansion. Additionally, variations in the availability of raw materials (methyltestosterone, etc.), their cost, regulatory compliance, pharmaceutical regulations, supplier reliability, sustainability practices, and efficient logistics impact industrial stanozolol procurement globally.
Raw Material for Stanozolol Production
According to the Stanozolol production plant project report, the major raw material for Stanozolol production includes Methyltestosterone.
Production Process of Stanozolol
The extensive Stanozolol production cost report consists of the following industrial production process:
- Production via Formylation: This method of production involves the process of reduction of the double bond at C4 and C5 in methyltestosterone to obtain stanozolol as the product. The process is initiated by the reduction of methyltestosterone to form an anabolic drug of mestanolone. Further, the obtained mestanolone undergoes formylation with ethylformate in the presence of sodium ethoxide to produce a derivative of 2-formyl (oxymethylene). Then, the obtained compound is further reacted with hydrazine, which results in the formation of 17α-Methyl-5α-androstano[3,2-c]pyrazol-17β-ol or stanozolol as the final product.
Stanozolol is an organic hetero-pentacyclic compound that is a derivative of dihydrotestosterone. The molecular formula of the compound is C21H32N2O, and its molecular weight is 328.5 g/mol. Moreover, the melting point of the compound is 242°C, and its boiling point is 490.8°C. The density of the compound is 1.129 gm/cm3, and its pka value is 15.15. The compound exists in the form of a white solid that is practically insoluble in water but is soluble in dimethylformamide. Additionally, it is recommended to store the compound between 2-8°C, and its flash point is -2.